NCT02753127 2023-11-15CanStem303CSumitomo Pharma America, Inc.Phase 3 Completed1,253 enrolled 18 charts
NCT00847912 2021-06-11VAKCCTVA Office of Research and DevelopmentPhase 4 Completed954 enrolled 11 charts